In this paper, we propose new types of non-convex functions called strongly --vex functions and semi strongly --vex functions. We study some properties of these proposed functions. As an application of these functions in optimization problems, we discuss some optimality properties of the generalized nonlinear optimization problem for which we use, as an objective function, strongly --vex function and semi strongly --vex function.

      In this paper we study and design two feed forward neural networks. The first approach uses radial basis function network and second approach uses wavelet basis function network to approximate the mapping from the input to the output space. The trained networks are then used in an conjugate gradient algorithm to estimate the output. These neural networks are then applied to solve differential equation. Results of applying these algorithms to several examples are presented

In this paper, we used the maximum likelihood estimation method to find the estimation values ​​for survival and hazard rate functions of the Exponential Rayleigh distribution based on a sample of the real data for lung cancer and stomach cancer obtained from the Iraqi Ministry of Health and Environment, Department of Medical City, Tumor Teaching Hospital, depending on patients' diagnosis records and number of days the patient remains in the hospital until his death.

The paper is concerned with posterior analysis of five exponentiated (Weibull, Exponential, Inverted Weibull, Pareto, Gumbel) distrebutions. The expressions for Bayes estimators of the shape parameters have been derived under four different prior distributions assuming four different loss functions. The posterior predictive distributions have been obtained, and the comparison between estimators made by using the mean squared errors through generated different sample sizes by using simulation technique. In general, the performance of estimators under Chi-square prior using squared error loss function is the best.

In this work an enzyme linked immunosorbent assay (ELISA) technique has been used for detection of some inflammatory markers in serum of acute coronary syndrome (ACS)-Patients Admitted to the cardiac care unit (CCU) of Iraqi Centre For Heart Diseases and Ibn AlNafees Teaching Hospital. The present method includes quantitative measurement of interleukine-6 (IL-6) and C-reactive protein (CRP), as their increase during symptoms may be responsible for identifying the mechanism of myocardial damag, in addition to their best performance than other quantitative tests perhaps due to their association with atherosclerotic process that belongs to the endothelial dysfunction. Aim of this study is to estimate the prevalence and correlation of IL-6 w

Background: Pleomorphic adenoma is the most common benign salivary gland tumor and shows a pronounced morphological complexity and diversity; for this The immunoprofiles and clinical course of PA differed according to cellular differentiation. Therefore, it is important to assess potential biomarkers in diagnostic and therapeutic trials. This study evaluates the immunohistochemical expression of D2-40, VEGF and PCNA as markers of lymphangiogenesis, angiogenesis and proliferation of PA and their correlation with clinicpathological parameters and with each other. Materials and Methods: Twenty five formalin – fixed, paraffin – embedded tissue blocks were included in this study. After histopathological reassessment of haematoxylin & eosin

Breast cancer is a disease in which cells in the breast grow out of control. CD200 is a cell surface glycoprotein expressed on many cells, it belongs to the immunoglobulin family (Ig) and have a great role in the regulation of inflammation in autoimmunity. CD200 is the ligand for CD200R1 receptor. To determine if serum level of CD200 and its receptor CD200R1 can be used as a diagnostic and prognostic marker in patients with breast cancer.This case control study was carried out at Oncology Teaching Hospital – Medical city in Baghdad. Six groups were enrolled, four groups were confirmed with breast cancer stage (I, II, III and IV), fifth group (benign) and sixth group was control (healthy individual). Serum is divided to me

BN Rashid, International Journal of Research in Social Sciences and Humanities, 2019 - Cited by 1